tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Cash flow

Compare
2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow

HK:9989's free cash flow for Q3 2025 was ¥398.02M. For the 2025 fiscal year, HK:9989's free cash flow was decreased by ¥2.04B and operating cash flow was ¥412.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 2.19B¥ 398.22M¥ -756.61M¥ -6.63M¥ 37.28M
Investing Cash Flow
¥ -415.05M¥ 1.22B¥ 249.84M¥ 719.93M¥ -2.17B
Financing Cash Flow
¥ -2.14B¥ -1.21B¥ 329.56M¥ -501.08M¥ 2.51B
End Cash Position
¥ 1.42B¥ 1.77B¥ 1.32B¥ 1.48B¥ 1.33B
Free Cash Flow
¥ 1.99B¥ -46.66M¥ -979.03M¥ -200.49M¥ -175.21M
Currency in CNY

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow